Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says

Notice · Comments reflect the author's own views, not those of this site. Posts that violate applicable laws (defamation, hate speech, misinformation, etc.) may be removed without notice. By posting you agree to our terms of use.